Viyash Scientific Limited announced the outcome of its Board Meeting held on February 05, 2026. The Board approved the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025. In line with the Composite Scheme of Amalgamation, the Board also approved the introduction and adoption of the "Viyash Scientific Limited Employee Stock Option Scheme 2026" (VSL ESOP Scheme 2026), subject to necessary approvals. This scheme will grant up to 1,34,75,000 stock options, representing 2.8% of the post-amalgamation paid-up share capital. Furthermore, the Board approved changes in Senior Management Personnel (SMP) of the Company, effective February 05, 2026, based on a comprehensive review of leadership roles to align with post-merger strategic objectives. The meeting commenced at 7:00 p.m. and concluded at 08:12 p.m.
